Literature DB >> 2303802

Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.

M Sällberg1, H Norder, L O Magnius.   

Abstract

The IgG subclasses IgM and IgA1 of antibodies to hepatitis B core antigen (anti-HBc) and hepatitis B e antigen (anti-HBe) were assayed in sera from 82 patients with chronic hepatitis B utilising class/subclass-specific enzyme immunoassays (EIA). The solid-phase was either recombinant hepatitis B core antigen (rHBcAg) or rHBcAg converted to HBeAg by addition of 0.1% SDS with remaining HBcAg antigenicity blocked with monoclonal anti-HBc. Anti-HBc IgG1 was detected in 81 sera at a geometrical mean titre (GMT) of 296,110 x divided by 2.9. Anti-HBc IgG2 was not detected in any of the sera, and anti-HBc IgG3 and IgG4 were detected in 50 and 37 sera, respectively. Anti-HBc IgM and IgA1 were both significantly correlated to the presence of HBV DNA. The predominant antibody to HBeAg was found to be IgG1, being detected in 45 sera with a GMT of 1,035 x divided by 3.3. Anti-HBe IgG2 was not detected in any serum, while anti-HBe IgG3 and IgG4 were found in 8 and 23 sera, respectively. Anti-HBe IgG1, IgG3, and IgG4 were mainly detected in sera positive for anti-HBe in RIA (Abbott). No patient was found positive for anti-HBe IgA1 or IgM. Thus, in contrast to HBcAg, HBeAg does not trigger a persistent IgM and IgA1 response in chronic hepatitis B. The levels of anti-HBe IgG1 and IgG3 were much lower than the levels of anti-HBc IgG1 and IgG3. The presence of anti-HBe IgG4 was significantly correlated to that of anti-HBc IgG4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303802     DOI: 10.1002/jmv.1890300102

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  Diversity of core antigen epitopes of hepatitis B virus.

Authors:  D M Belnap; N R Watts; J F Conway; N Cheng; S J Stahl; P T Wingfield; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

2.  Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance.

Authors:  S M Akbar; M Onji; Y Ohta
Journal:  Gastroenterol Jpn       Date:  1992-08

3.  The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.

Authors:  D R Milich; F Schödel; J L Hughes; J E Jones; D L Peterson
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

5.  Immunising infants at risk of hepatitis B. Parent held vaccination card may improve uptake.

Authors:  E H Boxall
Journal:  BMJ       Date:  1995-02-11

6.  IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.

Authors:  M Sällberg; H Norder; G Lindh; L O Magnius
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells.

Authors:  Jessica A Chichester; Mark A Feitelson; Catherine E Calkins
Journal:  Immunology       Date:  2006-06-06       Impact factor: 7.397

8.  Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.

Authors:  M Sällberg; U Rudén; B Wahren; L O Magnius
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.

Authors:  Weimin Wu; Zhaochun Chen; Naiqian Cheng; Norman R Watts; Stephen J Stahl; Patrizia Farci; Robert H Purcell; Paul T Wingfield; Alasdair C Steven
Journal:  J Struct Biol       Date:  2012-10-16       Impact factor: 2.867

10.  Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccinees.

Authors:  Lina Wang; Shyh-Jye Lin; Ju-Hsin Tsai; Chung-Hung Tsai; Chung-Chuan Tsai; Chi-Chiang Yang
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.